| Name | Title | Contact Details |
|---|---|---|
Alan Nelson |
Founder, Chairman and Chief Executive Officer | Profile |
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs.
At Target RWE, we are redefining and revolutionizing the generation and delivery of real-world evidence. Contact us today!
Bioriginal Food & Science Corp. is a Saskatoon, SK-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Ibis Biosciences a Division of Abbott is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Akero Therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.